drug safety evaluation

基本解釋

This paper analyzed and expressed the relationship and difference between non-clinical trial and ADR monitoring, lead a comprehensive understanding of drug safety evaluation.
本文旨在通過(guò)對(duì)藥品非臨床研究與ADR監(jiān)測(cè)區(qū)別與聯(lián)系的分析，闡明二者之間的聯(lián)系，使人們對(duì)藥品安全性評(píng)價(jià)加以全面的認(rèn)識(shí)。
kns50.chkd.cnki.net
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
心肌損傷生物標(biāo)志物的檢測(cè)在心臟疾病臨床診斷上被廣泛應(yīng)用，但是在新藥的非臨床安全評(píng)價(jià)方面，心肌損傷標(biāo)志物的應(yīng)用相對(duì)滯后。
The rapid development of toxicogenomics may also solve many problems happened in traditional animal toxicity experiments and to consummate further the system of drug safety evaluation and research.
以基因芯片技術(shù)為研究平臺(tái)的毒理基因組學(xué)的出現(xiàn)彌補(bǔ)了傳統(tǒng)毒性實(shí)驗(yàn)中存在的許多不足，并已對(duì)毒理學(xué)的研究方法、毒性評(píng)價(jià)的模式產(chǎn)生影響。

Adverse event reporting has a critical role in the evaluation of the safety of a drug or medical device during its testing.
FORBES: The Data On Drugs' Side Effects Must Be Reliable